Autopsy report · NCT04224662

A Pilot Study to Explore the Role of Gut Flora in Gout

“Company shifted focus”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

ProgenaBiome

Sponsor type

University, hospital or other

Conditions

Gout

Interventions

No intervention

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
  “Company focus shifted” (98% match in meaning)
• POMCO2 Clinical Study MicroTrend System pCO2 Sensor
  “Change in focus by the company.” (81% match in meaning)
• Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft vs Standard of Care in Participants With Dry Eye Disease
  “Change in company strategy.” (62% match in meaning)
• Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
  “company focus on other projects” (58% match in meaning)
• Awbat Versus Biobrane in Partial Thickness Burns
  “Company went out of business” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.